Here's Why Marijuana Stock Gw Pharmaceuticals Fell 13.3% In June

Shares of GW Pharmaceuticals (NASDAQ: GWPH) fell 13.3% in June, according to data provided by S&P Global Market Intelligence, despite the biotech gaining Food and Drug Administration approval for its epilepsy drug Epidiolex.For the most part, the stock market values companies based on expectations. Biotech companies often shoot up after positive binary events, such as FDA approvals or clinical trial results, because there's uncertainty about which way the event will go.

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News